FDA approves additional doses of Trulicity to treat type 2 diabetes
AWARD-11 showed 3.0 mg and 4.5 mg doses led to additional blood sugar control; as a secondary endpoint,…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
04 Sep 20
AWARD-11 showed 3.0 mg and 4.5 mg doses led to additional blood sugar control; as a secondary endpoint,…
04 Sep 20
Sanofi and GSK are scaling up the manufacturing of the antigen and adjuvant with the target of producing…
03 Sep 20
Janssen’s decision is based on results from the interim analyses of the Phase 3 clinical study of Pimodivir…
03 Sep 20
Parnell claims that its Nomovid is an easy-to-use and low-cost nasal spray product that can be rapidly commercialised…
02 Sep 20
The FDA approval is based on results from the Phase 3 QUAZAR AML-001 clinical trial, an international, randomised,…
02 Sep 20
JTX-1811 is a monoclonal antibody, designed to selectively target immunosuppressive tumor-infiltrating T regulatory (TITR) cells
01 Sep 20
The Phase III D8110C00001 trial will evaluate the safety, efficacy and immunogenicity of the AZD1222 vaccine in up…
31 Aug 20
Farxiga is the first medicine to significantly prolong survival in a renal outcomes trial in patients with chronic…
31 Aug 20
The EUA expands Veklury’s previous authorisation to treat hospitalised patients with Covid-19 regardless of oxygen status
28 Aug 20
IMO is a rare, severe autosomal recessive disorder is caused due to mutations in the TCIRG1 gene, which…